Jagsonpal Pharmaceuticals (India) Performance
| JAGSNPHARM | 639.65 23.25 3.77% |
On a scale of 0 to 100, Jagsonpal Pharmaceuticals holds a performance score of 14. The company retains a Market Volatility (i.e., Beta) of 0.94, which attests to possible diversification benefits within a given portfolio. Jagsonpal Pharmaceuticals returns are very sensitive to returns on the market. As the market goes up or down, Jagsonpal Pharmaceuticals is expected to follow. Please check Jagsonpal Pharmaceuticals' potential upside, and the relationship between the total risk alpha and kurtosis , to make a quick decision on whether Jagsonpal Pharmaceuticals' current trending patterns will revert.
Risk-Adjusted Performance
14 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Jagsonpal Pharmaceuticals Limited are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Jagsonpal Pharmaceuticals demonstrated solid returns over the last few months and may actually be approaching a breakup point. ...more
Forward Dividend Yield 0.0076 | Payout Ratio 0.5556 | Last Split Factor 2.5:1 | Forward Dividend Rate 5 | Ex Dividend Date 2024-09-06 |
1 | Mukul Agrawal Takes Fresh Position in Pharma Stock - Equitymaster | 11/07/2024 |
2 | Jagsonpal Pharmas Stock Reaches All-Time High, Outperforms Sector and Sensex - MarketsMojo | 11/25/2024 |
3 | Jagsonpal Pharmaceuticals Ltd. Reaches All-Time High, Outperforms Sector and Sensex - MarketsMojo | 11/26/2024 |
4 | Jagsonpal Pharmas Stock Reaches 52-Week High, Outperforms Sector and Sensex - MarketsMojo | 11/29/2024 |
| Begin Period Cash Flow | 110.5 M |
Jagsonpal |
Jagsonpal Pharmaceuticals Relative Risk vs. Return Landscape
If you would invest 41,430 in Jagsonpal Pharmaceuticals Limited on September 29, 2024 and sell it today you would earn a total of 22,535 from holding Jagsonpal Pharmaceuticals Limited or generate 54.39% return on investment over 90 days. Jagsonpal Pharmaceuticals Limited is generating 0.7921% of daily returns and assumes 4.3152% volatility on return distribution over the 90 days horizon. Simply put, 38% of stocks are less volatile than Jagsonpal, and 85% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Jagsonpal Pharmaceuticals Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Jagsonpal Pharmaceuticals' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Jagsonpal Pharmaceuticals Limited, and traders can use it to determine the average amount a Jagsonpal Pharmaceuticals' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1836
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | JAGSNPHARM | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.32 actual daily | 38 62% of assets are more volatile |
Expected Return
| 0.79 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.18 actual daily | 14 86% of assets perform better |
Based on monthly moving average Jagsonpal Pharmaceuticals is performing at about 14% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Jagsonpal Pharmaceuticals by adding it to a well-diversified portfolio.
Jagsonpal Pharmaceuticals Fundamentals Growth
Jagsonpal Stock prices reflect investors' perceptions of the future prospects and financial health of Jagsonpal Pharmaceuticals, and Jagsonpal Pharmaceuticals fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Jagsonpal Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.0605 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.19 % | ||||
| Current Valuation | 15.67 B | ||||
| Shares Outstanding | 26.55 M | ||||
| Price To Book | 8.30 X | ||||
| Price To Sales | 7.49 X | ||||
| Revenue | 2.09 B | ||||
| Gross Profit | 1.43 B | ||||
| EBITDA | 323.46 M | ||||
| Net Income | 224.63 M | ||||
| Cash And Equivalents | 110.53 M | ||||
| Total Debt | 89.41 M | ||||
| Book Value Per Share | 74.42 X | ||||
| Cash Flow From Operations | 351.66 M | ||||
| Earnings Per Share | 9.00 X | ||||
| Total Asset | 2.17 B | ||||
| Retained Earnings | 1.04 B | ||||
About Jagsonpal Pharmaceuticals Performance
By evaluating Jagsonpal Pharmaceuticals' fundamental ratios, stakeholders can gain valuable insights into Jagsonpal Pharmaceuticals' financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Jagsonpal Pharmaceuticals has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Jagsonpal Pharmaceuticals has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Jagsonpal Pharmaceuticals is entity of India. It is traded as Stock on NSE exchange.Things to note about Jagsonpal Pharmaceuticals performance evaluation
Checking the ongoing alerts about Jagsonpal Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Jagsonpal Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Jagsonpal Pharmaceuticals appears to be risky and price may revert if volatility continues | |
| About 76.0% of the company shares are held by company insiders |
- Analyzing Jagsonpal Pharmaceuticals' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Jagsonpal Pharmaceuticals' stock is overvalued or undervalued compared to its peers.
- Examining Jagsonpal Pharmaceuticals' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Jagsonpal Pharmaceuticals' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Jagsonpal Pharmaceuticals' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Jagsonpal Pharmaceuticals' stock. These opinions can provide insight into Jagsonpal Pharmaceuticals' potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Jagsonpal Stock analysis
When running Jagsonpal Pharmaceuticals' price analysis, check to measure Jagsonpal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Jagsonpal Pharmaceuticals is operating at the current time. Most of Jagsonpal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Jagsonpal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Jagsonpal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Jagsonpal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |